TRIALMED
Live / Applied — First extension granted (statement of use) (as of 05 Dec 2025)
What this means for you
Not registered yet, but its 13 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98750607
- Mark type
- Stylized text
- Filed
- 13 Sept 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Kenya Williams
Goods and services
- Class 035 — Advertising and business services: Business management of clinical trials for others; recruitment of clinical drug trial participants, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databases, namely, collecting and compiling consumer preference information regarding health conditions, clinical trial participation interest, and clinical trial candidacy for business purposes; collection of market research information, namely, collecting and compiling clinical trial statistics and information for business purposes
Owner
- Synexus Clinical Research US, Inc., Wilmington, NC, US
- Synexus Clinical Research US, Inc., Wilmington, NC, US
Prosecution history
- 17 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 06 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2025 — SOU EXTENSION 1 GRANTED
- 05 Dec 2025 — SOU EXTENSION 1 FILED
- 05 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2025 — ASSIGNED TO EXAMINER
- 24 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Sept 2024 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 20 Sept 2024 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 13 Sept 2024 — NEW APPLICATION ENTERED